Compelling evidence has been published across the country from leading universities such as Johns Hopkins on the use of psychedelic medicines such as psilocybin, MDMA, and ketamine to treat mental health conditions that do not respond to traditional pharmaceuticals. Ketamine is the first legal psychedelic medicine that is available to the U.S. public. In 2019, the FDA approved an intranasal formulation of ketamine, Spravato, which received breakthrough designation from the FDA. Ketamine is being hailed as the most significant development in psychiatry since the advent of SSRIs and has been shown consistently in the research to rapidly reverse suicidality. Ketamine is an effective treatment for various mental health conditions including: major depression, anxiety, PTSD, OCD, and bipolar disorder.
The efficacy of ketamine is significantly enhanced when combined with psychotherapy. Ketamine Assisted Psychotherapy or (KAP) utilizes the key principles of proper screening, preparation, set, setting, preparation, dosage, and integration to optimize safety/efficacy.
We believe the best way to learn and properly facilitate this modality to patients is to first experience it yourself; there is no replacement for direct experience.
To meet the demand in the Seattle area for training on this effective modality, AIMS institute is offering a 10-hr certificate in experiential KAP training specifically tailored for licensed providers.
- Screening/Preparation (1-2 hours)
- Intro/Fundamentals of KAP (Online Materials, Readings, 4.25 hours)
- Guided Experiential Session (3-hours)
- Integration (0.75 hours)
Cost of Training:
If you are on one of our accepted insurance plans (listed on our website aimsinstitute.net), your insurance plan is utilized for screening, preparation, and integration visits. The experiential ketamine and didactic training/recorded online materials and mindfold are not covered by insurance and is an out of pocket fee of $960 (+ tax for educational materials). If you are not on one of our accepted insurance plans, then out of pocket prices for screening, preparation, and integration would be applied. To apply email email@example.com or call (206) 420-1321.
Nathaniel Schmidt DNP, ARNP, PMHNP-BC is a psychiatric nurse practitioner who has worked in critical care, inpatient psychiatry, community mental health, and addiction. He completed his undergraduate degree at the University of Oklahoma and doctorate at the University of Washington. He is a graduate of the MAPS MDMA provider training program and has been a speaker with KRIYA Institute and the UW School of Nursing. He has been a featured speaker on Tangentially Speaking hosted by NY Times best-selling author Christopher Ryan and The Myths That Make Us hosted by Erick Godsey. He was a provider with AIMS Institute providing ketamine-assisted psychotherapy from 2018-2020.